The conference theme, “Food Safety Analysis,” will bring industry experts from around the world to discuss different aspects of this increasingly important topic, including food and beverage ...
BURLINGTON, Mass.--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, and Opentrons Labworks, Inc., a leader in lab automation and accessible ...
BILLERICA, Mass. & DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA*, a global pharmaceutical and chemical company, today announced the successful completion of its acquisition of Millipore Corporation ...
German pharmaceutical and chemical firm Merck KGaA has agreed to spend $7.2 billion to acquire Millipore, a maker of products for bioresearch and bioprocessing. After the acquisition, Merck will ...
Dublin, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The "Environmental Testing Products Company Evaluation Report" has been added to ResearchAndMarkets.com's offering. The Environmental Testing Companies ...
FRANKFURT (Reuters) - Drugs and chemicals maker Merck KGaA (MRCG.DE) agreed on Monday to acquire U.S.-based Sigma-Aldrich Corp (SIAL.O) for $17 billion (10.41 billion pounds) in cash to boost its lab ...
Merck to acquire all outstanding Millipore shares for US$ 107 per share in cash, creating a world-class partner for the life science sector Agreed transaction valued at approximately € 5.3 billion ...
On Nov. 18, Merck KGaA closed on the biggest acquisition in its 347-year history: The $17.0 billion purchase of the research-chemical supply house Sigma-Aldrich. Announced in September 2014, the deal ...
Through its U.S. and Canada life science business MilliporeSigma, Merck KGaA is acquiring Dutch company HUB Organoids. The deal is expected to be finalized by the end of 2024, according to a Dec. 17 ...
German drug and chemical conglomerate Merck has agreed to buy U.S. laboratory and biotech supply company Millipore in a deal valued at $7.2 billion, including assumption of debt. The deal would expand ...
FRANKFURT, March 1 (Reuters) - Merck KGaA's agreed $6 billion cash purchase of U.S. biotech tool maker Millipore buoyed the German drugmaker's share on Monday as it diversified away from its embattled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback